731 filings
Page 29 of 37
S-8
kgbuf0p
1 Feb 10
Registration of securities for employees
12:00am
8-K
j02rpm
29 Jan 10
Departure of Directors or Certain Officers
12:00am
8-K
v2p94nptgxy88 olcc3
25 Jan 10
Acorda Therapeutics Announces FDA Approval of
12:00am
8-K
kgf95il jk6odl2w
25 Jan 10
Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development
12:00am
8-K
lrmp1c9f
12 Jan 10
Other Events
12:00am
S-3ASR
jq309vi4q w7bxidae
12 Jan 10
Automatic shelf registration
12:00am
CT ORDER
hwuej mxz33p0nu
4 Nov 09
Confidential treatment order
12:00am
8-K
il9dlb6g
3 Nov 09
Results of Operations and Financial Condition
12:00am
8-K
yl6uw89u
22 Oct 09
Other Events
12:00am
8-K
rc66yk8
15 Oct 09
Acorda Therapeutics Announces Positive Vote by FDA Advisory Committee for Fampridine-SR
12:00am
8-K
2nilq3
14 Oct 09
Regulation FD Disclosure
12:00am
8-K
ptylqfh4zvyhafoh
9 Oct 09
Acorda Therapeutics Announces Posting of Briefing Documents for October 14
12:00am
8-K
42lhb
15 Sep 09
Acorda Therapeutics Announces Data on Retention Rates and Safety from
12:00am
8-K
453ww cd4naxd6
10 Sep 09
Acorda Therapeutics Announces Interim Analysis of Two-Year Efficacy and Safety Data from Phase 3 Fampridine-SR Extension Study
12:00am
8-K
ql4c5sj epnxhsph5
25 Aug 09
Acorda Therapeutics Reports Date of FDA Advisory Committee Review of Fampridine-SR for Improvement of Walking Ability in People with MS
12:00am
8-K
ootcoljd85
4 Aug 09
Results of Operations and Financial Condition
12:00am
8-K
zqgjz c5drguv
1 Jul 09
Entry into a Material Definitive Agreement
12:00am
8-K
31ti839nyzv c787ohu
8 Jun 09
Other Events
12:00am